Literature DB >> 12523662

Impact of omission or replacement of data below the limit of quantification on parameter estimates in a two-compartment model.

Vincent Duval1, Mats O Karlsson.   

Abstract

PURPOSE: To evaluate the influence of omission and replacement approaches for data below the limit of quantification (LOQ) on the estimation of pharmacokinetic parameters for two-compartment models when using nonlinear mixed-effect models.
METHOD: Nine data sets were simulated according to a two-compartment intravenous bolus model with interindividual and residual variabilities, and a sparse sampling strategy was adopted. The data sets differed with respect to area-under-the-curve (AUC) ratio (0.1. 0.2, 0.3) and half-life ratio (0.03, 0.1, 0.3) between the distribution and elimination phases. For each of the nine data sets, six reduced data sets were created by omitting 5%, 10%, 20%, 30%, 40%, or 50% of the lowest concentration values. For each of the reduced data sets only one simple correction procedure to handle observations below LOQ was applied. All the values below the LOQ were deleted, and the first one was replaced by half of the LOQ value. Population parameters were estimated for each of the 117 resulting data sets (one initial, six reduced, and six "corrected" data sets for each of the nine cases). This approach was also applied on a real data set of patients administered multiple i.v. bolus doses.
RESULTS: For many of the data sets, particularly when a large fraction of the data was omitted, one or several population parameters were biased. When there was bias, clearance (CL) usually was underestimated, whereas peripheral volume was overestimated. The parameters related to the distribution phase (central volume and intercompartmental clearance) were less affected, and changes were not systematic. The correction procedure markedly decreased overall bias on the fixed effect of the parameters. Results for the real data were similar.
CONCLUSION: Omission of data below the LOQ value may induce a not negligible bias on fixed-effect parameter estimates. The influence of the omission of values below LOQ was related to the underlying shape of the concentration-time profile and fraction of omitted observations. The use of a simple replacement rule seems to reduce this bias in estimates but needs further investigation.

Entities:  

Mesh:

Year:  2002        PMID: 12523662     DOI: 10.1023/a:1021441407898

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  6 in total

Review 1.  Pharmacokinetic/pharmacodynamic modeling in drug development.

Authors:  L B Sheiner; J L Steimer
Journal:  Annu Rev Pharmacol Toxicol       Date:  2000       Impact factor: 13.820

2.  Some statistical issues in modelling pharmacokinetic data.

Authors:  J K Lindsey; B Jones; P Jarvis
Journal:  Stat Med       Date:  2001 Sep 15-30       Impact factor: 2.373

3.  Ways to fit a PK model with some data below the quantification limit.

Authors:  S L Beal
Journal:  J Pharmacokinet Pharmacodyn       Date:  2001-10       Impact factor: 2.745

4.  Analysis of toxicokinetic data using NONMEM: impact of quantification limit and replacement strategies for censored data.

Authors:  J P Hing; S G Woolfrey; D Greenslade; P M Wright
Journal:  J Pharmacokinet Pharmacodyn       Date:  2001-10       Impact factor: 2.745

Review 5.  Multiple imputation: a primer.

Authors:  J L Schafer
Journal:  Stat Methods Med Res       Date:  1999-03       Impact factor: 3.021

Review 6.  Population pharmacokinetics/dynamics.

Authors:  L B Sheiner; T M Ludden
Journal:  Annu Rev Pharmacol Toxicol       Date:  1992       Impact factor: 13.820

  6 in total
  25 in total

1.  Use of pharmacokinetic data below lower limit of quantitation values.

Authors:  William J Jusko
Journal:  Pharm Res       Date:  2012-06-23       Impact factor: 4.200

2.  Impact of censoring data below an arbitrary quantification limit on structural model misspecification.

Authors:  Wonkyung Byon; Courtney V Fletcher; Richard C Brundage
Journal:  J Pharmacokinet Pharmacodyn       Date:  2007-10-26       Impact factor: 2.745

3.  Handling data below the limit of quantification in mixed effect models.

Authors:  Martin Bergstrand; Mats O Karlsson
Journal:  AAPS J       Date:  2009-05-19       Impact factor: 4.009

4.  Likelihood based approaches to handling data below the quantification limit using NONMEM VI.

Authors:  Jae Eun Ahn; Mats O Karlsson; Adrian Dunne; Thomas M Ludden
Journal:  J Pharmacokinet Pharmacodyn       Date:  2008-08-07       Impact factor: 2.745

5.  Multinomial logistic functions in markov chain models of sleep architecture: internal and external validation and covariate analysis.

Authors:  Roberto Bizzotto; Stefano Zamuner; Enrica Mezzalana; Giuseppe De Nicolao; Roberto Gomeni; Andrew C Hooker; Mats O Karlsson
Journal:  AAPS J       Date:  2011-06-21       Impact factor: 4.009

6.  Impact of low percentage of data below the quantification limit on parameter estimates of pharmacokinetic models.

Authors:  Xu Steven Xu; Adrian Dunne; Holly Kimko; Partha Nandy; An Vermeulen
Journal:  J Pharmacokinet Pharmacodyn       Date:  2011-05-31       Impact factor: 2.745

7.  Extension of NPDE for evaluation of nonlinear mixed effect models in presence of data below the quantification limit with applications to HIV dynamic model.

Authors:  Thi Huyen Tram Nguyen; Emmanuelle Comets; France Mentré
Journal:  J Pharmacokinet Pharmacodyn       Date:  2012-08-11       Impact factor: 2.745

8.  Improvement of Parameter Estimations in Tumor Growth Inhibition Models on Xenografted Animals: a Novel Method to Handle the Interval Censoring Caused by Measurement of Smaller Tumors.

Authors:  Philippe B Pierrillas; Michel Tod; Magali Amiel; Marylore Chenel; Emilie Henin
Journal:  AAPS J       Date:  2016-01-12       Impact factor: 4.009

9.  Semi-mechanistic population pharmacokinetic drug-drug interaction modelling of a long half-life substrate and itraconazole.

Authors:  Thorsten Lehr; Alexander Staab; Dirk Trommeshauser; Hans Guenter Schaefer; Charlotte Kloft
Journal:  Clin Pharmacokinet       Date:  2010       Impact factor: 6.447

10.  Comparison of models for analyzing two-group, cross-sectional data with a Gaussian outcome subject to a detection limit.

Authors:  Ryan E Wiegand; Charles E Rose; John M Karon
Journal:  Stat Methods Med Res       Date:  2014-05-05       Impact factor: 3.021

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.